121 related articles for article (PubMed ID: 22243633)
1. Enriched pathways for major depressive disorder identified from a genome-wide association study.
Kao CF; Jia P; Zhao Z; Kuo PH
Int J Neuropsychopharmacol; 2012 Nov; 15(10):1401-11. PubMed ID: 22243633
[TBL] [Abstract][Full Text] [Related]
2. Cell adhesion molecules contribute to Alzheimer's disease: multiple pathway analyses of two genome-wide association studies.
Liu G; Jiang Y; Wang P; Feng R; Jiang N; Chen X; Song H; Chen Z
J Neurochem; 2012 Jan; 120(1):190-8. PubMed ID: 22017384
[TBL] [Abstract][Full Text] [Related]
3. Pathway analysis using information from allele-specific gene methylation in genome-wide association studies for bipolar disorder.
Chuang LC; Kao CF; Shih WL; Kuo PH
PLoS One; 2013; 8(1):e53092. PubMed ID: 23326387
[TBL] [Abstract][Full Text] [Related]
4. Genetic Pathways and Functional Subnetworks for the Complex Nature of Bipolar Disorder in Genome-Wide Association Study.
Kuo CY; Chen TY; Kao PH; Huang W; Cho CR; Lai YS; Yiang GT; Kao CF
Front Mol Neurosci; 2021; 14():772584. PubMed ID: 34880727
[TBL] [Abstract][Full Text] [Related]
5. Gene expression in major depressive disorder.
Jansen R; Penninx BW; Madar V; Xia K; Milaneschi Y; Hottenga JJ; Hammerschlag AR; Beekman A; van der Wee N; Smit JH; Brooks AI; Tischfield J; Posthuma D; Schoevers R; van Grootheest G; Willemsen G; de Geus EJ; Boomsma DI; Wright FA; Zou F; Sun W; Sullivan PF
Mol Psychiatry; 2016 Mar; 21(3):339-47. PubMed ID: 26008736
[TBL] [Abstract][Full Text] [Related]
6. Identifying SNP targeted pathways in partial epilepsies with genome-wide association study data.
Bakir-Gungor B; Baykan B; Ugur İseri S; Tuncer FN; Sezerman OU
Epilepsy Res; 2013 Jul; 105(1-2):92-102. PubMed ID: 23498093
[TBL] [Abstract][Full Text] [Related]
7. Prioritization and comprehensive analysis of genes related to major depressive disorder.
Liu Y; Fan P; Zhang S; Wang Y; Liu D
Mol Genet Genomic Med; 2019 Jun; 7(6):e659. PubMed ID: 30968596
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive network and pathway analysis of candidate genes in major depressive disorder.
Jia P; Kao CF; Kuo PH; Zhao Z
BMC Syst Biol; 2011; 5 Suppl 3(Suppl 3):S12. PubMed ID: 22784618
[TBL] [Abstract][Full Text] [Related]
9. Discovering new genetic and psychosocial pathways in Major Depressive Disorder: the NewMood project.
Freeborough A; Kimpton J
Psychiatr Danub; 2011 Sep; 23 Suppl 1():S138-41. PubMed ID: 21894122
[TBL] [Abstract][Full Text] [Related]
10. A continuum of genetic liability for minor and major depression.
Corfield EC; Yang Y; Martin NG; Nyholt DR
Transl Psychiatry; 2017 May; 7(5):e1131. PubMed ID: 28509901
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetic overlap between migraine and major depressive disorder.
Yang Y; Zhao H; Boomsma DI; Ligthart L; Belin AC; Smith GD; Esko T; Freilinger TM; Hansen TF; Ikram MA; Kallela M; Kubisch C; Paraskevi C; Strachan DP; Wessman M; ; van den Maagdenberg AMJM; Terwindt GM; Nyholt DR
Eur J Hum Genet; 2018 Aug; 26(8):1202-1216. PubMed ID: 29995844
[TBL] [Abstract][Full Text] [Related]
12. Genetic association analysis of functional polymorphisms in neuronal nitric oxide synthase 1 gene (NOS1) and mood disorders and fluvoxamine response in major depressive disorder in the Japanese population.
Okumura T; Kishi T; Okochi T; Ikeda M; Kitajima T; Yamanouchi Y; Kinoshita Y; Kawashima K; Tsunoka T; Inada T; Ozaki N; Iwata N
Neuropsychobiology; 2010; 61(2):57-63. PubMed ID: 20016223
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide association study knowledge-driven pathway analysis of alcohol dependence implicates the calcium signaling pathway.
Li D; Li J; Guo Y
Chin Med J (Engl); 2014; 127(12):2229-35. PubMed ID: 24931233
[TBL] [Abstract][Full Text] [Related]
14. Identify novel, shared and disorder-specific genetic architecture of major depressive disorder, insomnia and chronic pain.
Zheng H; Sun J; Pang T; Liu J; Lu L; Chang S
J Psychiatr Res; 2022 Nov; 155():511-517. PubMed ID: 36191519
[TBL] [Abstract][Full Text] [Related]
15. A gene co-expression network-based analysis of multiple brain tissues reveals novel genes and molecular pathways underlying major depression.
Gerring ZF; Gamazon ER; Derks EM;
PLoS Genet; 2019 Jul; 15(7):e1008245. PubMed ID: 31306407
[TBL] [Abstract][Full Text] [Related]
16. Poor replication of candidate genes for major depressive disorder using genome-wide association data.
Bosker FJ; Hartman CA; Nolte IM; Prins BP; Terpstra P; Posthuma D; van Veen T; Willemsen G; DeRijk RH; de Geus EJ; Hoogendijk WJ; Sullivan PF; Penninx BW; Boomsma DI; Snieder H; Nolen WA
Mol Psychiatry; 2011 May; 16(5):516-32. PubMed ID: 20351714
[TBL] [Abstract][Full Text] [Related]
17. Biological pathway-based genome-wide association analysis identified the vasoactive intestinal peptide (VIP) pathway important for obesity.
Liu YJ; Guo YF; Zhang LS; Pei YF; Yu N; Yu P; Papasian CJ; Deng HW
Obesity (Silver Spring); 2010 Dec; 18(12):2339-46. PubMed ID: 20379146
[TBL] [Abstract][Full Text] [Related]
18. BDgene: a genetic database for bipolar disorder and its overlap with schizophrenia and major depressive disorder.
Chang SH; Gao L; Li Z; Zhang WN; Du Y; Wang J
Biol Psychiatry; 2013 Nov; 74(10):727-33. PubMed ID: 23764453
[TBL] [Abstract][Full Text] [Related]
19. Genetic overlap between type 2 diabetes and major depressive disorder identified by bioinformatics analysis.
Ji HF; Zhuang QS; Shen L
Oncotarget; 2016 Apr; 7(14):17410-4. PubMed ID: 27007159
[TBL] [Abstract][Full Text] [Related]
20. GSEA-SNP: applying gene set enrichment analysis to SNP data from genome-wide association studies.
Holden M; Deng S; Wojnowski L; Kulle B
Bioinformatics; 2008 Dec; 24(23):2784-5. PubMed ID: 18854360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]